FDA Clears Tubeless Automated Insulin Delivery System for People with Diabetes
6 Articles
6 Articles
FDA clears tubeless automated insulin delivery system for people with diabetes
The FDA has cleared a tubeless cartridge and infusion set to be used with an automated insulin delivery system for people with diabetes, according to a press release from Tandem Diabetes Care.The Tandem Mobi tubeless cartridge and infusion set will allow users to convert the current tubed Tandem Mobi insulin pump into a tubeless device. Tandem Mobi uses Control-IQ+ technology to predict glucose
Tandem’s Mobi pump wins FDA clearance for 7-day tubeless wear
Tandem Diabetes Care (Nasdaq: TNDM) has secured an FDA clearance for a tubeless version of its miniaturized automated insulin delivery system. The Tandem Mobi’s new cartridge and infusion set converts the pump into a device that can be worn on the skin for up to a week, beating Insulet Omnipod 5’s wear time of 3 […]
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium





